See more : Hortifrut S.A. (HF.SN) Income Statement Analysis – Financial Results
Complete financial analysis of Danone S.A. (DANOY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danone S.A., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- f-code Inc. (9211.T) Income Statement Analysis – Financial Results
- Kenedix Retail REIT Corporation (3453.T) Income Statement Analysis – Financial Results
- UNIRITA Inc. (3800.T) Income Statement Analysis – Financial Results
- Polynet Public Company Limited (POLY.BK) Income Statement Analysis – Financial Results
- Celon Pharma S.A. (CLN.WA) Income Statement Analysis – Financial Results
Danone S.A. (DANOY)
About Danone S.A.
Danone S.A. operates in the food and beverage industry in Europe, Noram, Latin America, the Asia Pacific, Africa, and the Middle East. The company operates through three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. It produces and distributes yogurts; milk products; coffee creamers, drinks, and beverages; plant-based products; and ice creams, desserts, and nutritional powdered protein products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, as well as under the licensed brands, including International Delight, Dunkin' Donuts, and Bailey's. The company also offers specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics brands. In addition, it provides tube feeding products under the Nutrison name; oral nutritional supplements under the Fortimel and NutriDrink names; and hypoallergenic products for children with allergies primarily under the Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo names. Further, the company offers water with natural fruit extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 27.62B | 27.66B | 24.28B | 23.62B | 25.29B | 24.65B | 24.68B | 21.94B | 22.41B | 21.14B | 21.30B | 20.87B | 19.32B | 17.01B | 14.98B | 15.22B | 12.78B | 14.07B | 13.01B | 13.69B | 13.11B | 13.57B | 14.50B | 14.33B | 13.33B | 12.92B | 13.35B |
Cost of Revenue | 14.54B | 14.92B | 12.76B | 12.27B | 12.88B | 12.73B | 12.46B | 10.74B | 11.21B | 11.06B | 10.98B | 10.41B | 9.54B | 7.96B | 6.75B | 7.17B | 6.38B | 7.21B | 6.64B | 6.36B | 5.97B | 6.45B | 7.43B | 7.23B | 6.04B | 6.10B | 6.66B |
Gross Profit | 13.08B | 12.74B | 11.52B | 11.35B | 12.41B | 11.92B | 12.22B | 11.20B | 11.20B | 10.09B | 10.32B | 10.46B | 9.78B | 9.05B | 8.23B | 8.05B | 6.40B | 6.86B | 6.38B | 7.33B | 7.14B | 7.12B | 7.07B | 7.10B | 7.29B | 6.82B | 6.69B |
Gross Profit Ratio | 47.37% | 46.05% | 47.45% | 48.07% | 49.07% | 48.36% | 49.51% | 51.04% | 49.97% | 47.71% | 48.46% | 50.12% | 50.61% | 53.21% | 54.95% | 52.88% | 50.06% | 48.74% | 48.99% | 53.51% | 54.43% | 52.48% | 48.75% | 49.54% | 54.71% | 52.81% | 50.10% |
Research & Development | 398.00M | 339.00M | 338.00M | 323.00M | 351.00M | 335.00M | 342.00M | 333.00M | 307.00M | 272.00M | 275.00M | 257.00M | 233.00M | 209.00M | 206.00M | 198.00M | 121.00M | 126.00M | 123.27M | 130.57M | 129.43M | 133.42M | 125.88M | 125.64M | 122.24M | 120.14M | 114.36M |
General & Administrative | 2.75B | 2.64B | 2.33B | 2.29B | 2.39B | 2.22B | 2.23B | 2.00B | 1.94B | 1.74B | 1.71B | 1.75B | 1.56B | 1.49B | 1.36B | 1.30B | 943.00M | 1.05B | 4.34B | 5.29B | 5.14B | 5.14B | 5.33B | 5.42B | 5.02B | 4.50B | 4.41B |
Selling & Marketing | 6.29B | 6.29B | 5.52B | 5.37B | 5.77B | 5.64B | 5.89B | 5.56B | 5.68B | 5.21B | 5.43B | 5.47B | 5.09B | 4.66B | 4.21B | 4.20B | 3.50B | 3.61B | -3.11B | 3.11B | -4.33B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.04B | 8.93B | 7.84B | 7.65B | 8.16B | 7.86B | 8.12B | 7.57B | 7.62B | 6.95B | 7.13B | 7.22B | 5.09B | 6.16B | 5.57B | 5.49B | 4.44B | 4.65B | 4.34B | 5.29B | 5.14B | 5.14B | 5.33B | 5.42B | 5.02B | 4.50B | 4.41B |
Other Expenses | 1.61B | 53.00M | 39.00M | 44.00M | 95.00M | 60.00M | 62.00M | -23.00M | -64.00M | -16.00M | -221.00M | -6.00M | 67.00M | 107.00M | -77.00M | 169.00M | 288.00M | 135.00M | 202.63M | -239.01M | -227.09M | 264.93M | -654.12M | 59.63M | 760.25M | 701.14M | 728.27M |
Operating Expenses | 11.04B | 9.32B | 8.22B | 8.02B | 8.60B | 9.23B | 8.49B | 8.22B | 8.21B | 7.46B | 7.47B | 7.54B | 7.05B | 6.47B | 5.94B | 5.86B | 4.85B | 4.91B | 4.67B | 5.62B | 5.53B | 5.53B | 5.45B | 5.54B | 5.90B | 5.32B | 5.26B |
Cost & Expenses | 25.58B | 24.25B | 20.98B | 20.29B | 21.48B | 21.95B | 20.95B | 18.96B | 19.42B | 18.52B | 18.45B | 17.94B | 16.59B | 14.43B | 12.69B | 13.03B | 11.23B | 12.13B | 11.31B | 11.99B | 11.51B | 11.98B | 12.88B | 12.77B | 11.94B | 11.42B | 11.92B |
Interest Income | 156.00M | 155.00M | 156.00M | 151.00M | 181.00M | 162.00M | 151.00M | 130.00M | 122.00M | 94.00M | 76.00M | 75.00M | 67.00M | 87.00M | 76.00M | 58.00M | 132.00M | 182.00M | 88.00M | 55.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 513.00M | 308.00M | 323.00M | 358.00M | 400.00M | 393.00M | 414.00M | 276.00M | 274.00M | 274.00M | 269.00M | 245.00M | 241.00M | 230.00M | 264.00M | 497.00M | 307.00M | 219.00M | 189.00M | 149.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.61B | 1.86B | 1.27B | 1.45B | 1.39B | 863.00M | 830.00M | 754.00M | 1.22B | 956.00M | 710.00M | 670.00M | -46.00M | 594.00M | 549.00M | 525.00M | 420.00M | 491.00M | 477.88M | 558.42M | 597.90M | 721.40M | 778.87M | 759.16M | 760.25M | 701.14M | 728.27M |
EBITDA | 3.81B | 4.00B | 3.58B | 4.30B | 4.65B | 4.39B | 4.68B | 3.69B | 3.42B | 3.07B | 3.47B | 3.36B | 3.31B | 2.52B | 2.91B | 2.57B | 2.10B | 2.52B | 2.26B | 2.20B | 2.20B | 2.31B | 2.39B | 2.31B | 2.16B | 2.21B | 2.16B |
EBITDA Ratio | 13.79% | 18.36% | 19.18% | 20.41% | 20.69% | 17.85% | 19.21% | 16.98% | 18.44% | 16.70% | 15.25% | 16.26% | 14.13% | 19.48% | 18.92% | 17.25% | 16.41% | 18.39% | 16.77% | 16.53% | 16.78% | 17.05% | 16.49% | 16.15% | 16.17% | 17.07% | 16.18% |
Operating Income | 2.04B | 3.22B | 3.39B | 2.80B | 3.24B | 2.74B | 3.73B | 2.92B | 2.21B | 2.15B | 2.13B | 2.75B | 2.73B | 2.58B | 2.51B | 2.19B | 1.55B | 1.87B | 1.70B | 1.70B | 1.60B | 1.59B | 1.61B | 1.55B | 1.40B | 1.50B | 1.43B |
Operating Income Ratio | 7.39% | 11.62% | 13.97% | 11.85% | 12.80% | 11.12% | 15.13% | 13.32% | 9.86% | 10.17% | 9.99% | 13.16% | 14.13% | 15.16% | 16.76% | 14.37% | 12.10% | 13.32% | 13.10% | 12.45% | 12.22% | 11.73% | 11.12% | 10.85% | 10.47% | 11.64% | 10.73% |
Total Other Income/Expenses | -321.00M | -311.00M | -262.00M | -310.00M | -370.00M | -348.00M | -437.00M | -293.00M | -285.00M | -312.00M | -263.00M | -329.00M | -294.00M | -20.00M | -489.00M | -584.00M | -177.00M | -68.00M | -110.00M | -33.48M | -276.32M | 183.92M | -1.06B | -268.31M | -210.68M | -473.91M | -432.64M |
Income Before Tax | 1.72B | 1.83B | 2.00B | 2.49B | 2.87B | 2.39B | 3.30B | 2.63B | 1.93B | 1.84B | 1.87B | 2.45B | 2.44B | 2.49B | 2.02B | 1.60B | 1.37B | 1.81B | 1.59B | 1.53B | 1.33B | 1.78B | 549.59M | 1.29B | 1.18B | 1.03B | 999.91M |
Income Before Tax Ratio | 6.23% | 6.62% | 8.22% | 10.53% | 11.34% | 9.71% | 13.36% | 11.99% | 8.59% | 8.70% | 8.76% | 11.72% | 12.60% | 14.63% | 13.50% | 10.53% | 10.72% | 12.83% | 12.26% | 11.14% | 10.11% | 13.09% | 3.79% | 8.98% | 8.89% | 7.97% | 7.49% |
Income Tax Expense | 768.00M | 778.00M | 589.00M | 762.00M | 793.00M | 716.00M | 842.00M | 804.00M | 626.00M | 599.00M | 604.00M | 712.00M | 626.00M | 576.00M | 424.00M | 443.00M | 410.00M | 360.00M | 472.81M | 456.62M | 487.53M | 490.78M | 416.97M | 563.25M | 500.87M | 432.98M | 447.00M |
Net Income | 881.00M | 959.00M | 1.41B | 1.96B | 1.92B | 2.34B | 2.45B | 1.72B | 1.28B | 1.12B | 1.42B | 1.67B | 1.67B | 1.88B | 1.36B | 1.31B | 4.18B | 1.35B | 1.46B | 316.46M | 837.70M | 1.28B | 132.62M | 722.96M | 683.73M | 597.37M | 552.91M |
Net Income Ratio | 3.19% | 3.47% | 5.79% | 8.28% | 7.57% | 9.47% | 9.92% | 7.84% | 5.72% | 5.29% | 6.68% | 8.01% | 8.65% | 11.02% | 9.08% | 8.63% | 32.72% | 9.61% | 11.25% | 2.31% | 6.39% | 9.47% | 0.91% | 5.05% | 5.13% | 4.62% | 4.14% |
EPS | 1.35 | 1.48 | 2.18 | 2.99 | 2.95 | 0.73 | 0.78 | 0.56 | 0.42 | 0.38 | 0.48 | 0.56 | 0.55 | 0.61 | 0.48 | 0.53 | 1.75 | 0.56 | 0.60 | 0.13 | 0.33 | 0.49 | 0.05 | 0.26 | 0.24 | 0.21 | 0.20 |
EPS Diluted | 1.36 | 1.48 | 2.17 | 2.99 | 2.95 | 0.73 | 0.78 | 0.56 | 0.42 | 0.38 | 0.48 | 0.55 | 0.55 | 0.61 | 0.48 | 0.53 | 1.74 | 0.55 | 0.59 | 0.12 | 0.32 | 0.47 | 0.05 | 0.26 | 0.24 | 0.20 | 0.19 |
Weighted Avg Shares Out | 647.79M | 639.05M | 646.16M | 649.33M | 648.25M | 3.21B | 3.13B | 3.08B | 3.05B | 2.97B | 2.94B | 3.00B | 3.01B | 3.07B | 2.83B | 2.46B | 2.38B | 2.43B | 2.46B | 2.51B | 2.55B | 2.64B | 2.79B | 2.81B | 2.79B | 2.80B | 2.83B |
Weighted Avg Shares Out (Dil) | 641.74M | 639.48M | 646.45M | 649.97M | 649.11M | 3.22B | 3.14B | 3.08B | 3.05B | 2.98B | 2.94B | 3.02B | 3.02B | 3.08B | 2.83B | 2.47B | 2.40B | 2.45B | 2.50B | 2.58B | 2.63B | 2.74B | 2.85B | 2.83B | 2.97B | 2.92B | 2.93B |
Lifeway Provides Additional Information Regarding Reasons for Rejecting Danone's Revised Proposal
Evian maker Danone defeats lawsuit over ‘carbon neutral' claim: ‘Technically true'
Evian maker Danone defeats lawsuit over 'carbon neutral' claim
Baby milk formula suppliers face direct price action unless competition improves, says CMA
Edward and Ludmila Smolyansky Support Danone Bid to Acquire Lifeway Foods (NASDAQ: LWAY)
Danone wins dismissal of Evian microplastics lawsuit in Chicago
Lifeway Foods rejects Danone takeover offer, adopts shareholder rights plan
INGR vs. DANOY: Which Stock Should Value Investors Buy Now?
Danone S.A. (DANOY) Q3 2024 Earnings Conference Call Transcript
Danone Sales Growth Beats Market Expectations
Source: https://incomestatements.info
Category: Stock Reports